Clinical Trials Directory

Trials / Terminated

TerminatedNCT03918603

Decrease of Lesions Induced by Mechanical Ventilation During ARDS

Reduction of Mechanical Ventilation-induced Lesions During ARDS With Multimodal Ultra-protective Ventilation in Combination With ECMO

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
38 (actual)
Sponsor
Assistance Publique Hopitaux De Marseille · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Modification of mechanically ventilated lesions by an ultra-protective multimodal strategy compared to a protective strategy in patients with veno-venous ECMO for severe ARDS.

Detailed description

the hypothesis is that ECMO, in addition to improving gas exchange, should limit the deleterious effects of mechanical ventilation (mechanical ventilation-induced lesions, VILI) by drastically reducing minute ventilation (volume reduction). current, Vt, reduction of respiratory rate, reduction of mechanical power, reduction of motor pressure or driving pressure), adapting the level of PEEP from the data collected by monitoring oesophageal pressure and systematically performing positioning sessions in the prone position. This ultra-protective strategy could thus promote the restoration of the integrity of the alveolo-capillary membrane and thus facilitate the healing of patients. In order to verify this concept and, if necessary, to propose a study whose objectives would be more clinical (mortality, ventilator-free days), we propose to carry out a study aimed at showing that this ultra-protective multimodal strategy reduces the lesions induced by mechanical ventilation compared to usual protective ventilatory management during the ECMO as proposed in the EOLIA study.

Conditions

Interventions

TypeNameDescription
OTHERventral décubitusPatient will have one session at least more than 12 hours between inclusion and H48 of ventral décubitus

Timeline

Start date
2019-07-03
Primary completion
2021-04-23
Completion
2021-06-23
First posted
2019-04-17
Last updated
2023-07-20

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03918603. Inclusion in this directory is not an endorsement.